Kenadyr Metals Corp
KEN.H
Katipult Technology Corp
FUND
KWESST Micro Systems Inc
KWE
Champion Bear Resources Ltd
CBA
Blue Horizon Global Capital Corp
BHCC
Marvel Biosciences Corp is a life sciences company focused on the discovery and development of a synthetic derivative compound of a known drug. It has developed several new chemical entities, using synthetic chemical derivatives of known, off-patent drugs, that inhibit the A2a adenosine receptor with application to neurological diseases (depression & anxiety, Alzheimer’s, ADHD), and the non-neurological conditions of cancer and non-alcoholic steatohepatitis. Marvel is also exploring additional undisclosed targets to expand its asset pipeline.